Pittenger & Anderson’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Pittenger & Anderson's LLY Position: Q3 2026 in Review
Pittenger & Anderson increased its Eli Lilly (LLY) stake by 0.65% in Q3 2026, buying an estimated $8.26K and bringing the position to 1,084 shares worth $1.25M. The position accounts for 0.05% of the portfolio, ranked #165.
Pittenger & Anderson first reported a position in LLY in Q2 2013 and has held it in 27 quarters since. The position peaked at $1.29M in Q2 2026. 4,624 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Pittenger & Anderson held 1,084 shares of Eli Lilly worth $1.25M as of Q3 2026.
- Pittenger & Anderson bought 7 Eli Lilly shares in Q3 2026, an estimated $8.26K.
- Eli Lilly made up 0.05% of Pittenger & Anderson's portfolio in Q3 2026, its #165 holding.
- Pittenger & Anderson first reported a position in Eli Lilly in Q2 2013 and has held it in 27 quarters since.
- Pittenger & Anderson's Eli Lilly position peaked at $1.29M in Q2 2026.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Pittenger & Anderson's 13F filing for Q3 2026, filed 2 Nov 2026.